PTK2 and neoplasm: The main findings were that the EphA2-knockdown group exhibited (1) decreased numbers of tumor cells, as measured using BLI, (2) increased tumor cell apoptosis, as determined by the TUNEL assay, (3) suppressed FAK/RhoA pathway activation, and (4) reduced tumor wet weight compared to the results in the control group.